TY - JOUR
T1 - Modulation of P450CYP3A4-dependent metabolism by P-glycoprotein: implications for P450 phenotyping
AU - Baron, Jens M.
AU - Goh, Lay Beng
AU - Yao, Denggao
AU - Wolf, C. Roland
AU - Friedberg, Thomas
N1 - dc.publisher: American Society for Pharmacology and Experimental Therapeutics
dc.description.sponsorship: German Research Council
PY - 2001
Y1 - 2001
N2 - Some compounds used for phenotyping of cytochrome P450s are substrates of P-glycoprotein (pgp). It is likely that in these cases, the level of modulates the metabolism of in vivo probes. To address this important issue, we have analyzed the effects of pgp on CYP3A4-mediated reactions in two established cell lines (3A4/HR/MDR-and 3A4/HR/MDR+), which express CYP3A4 in the absence and presence of pgp respectively. In cultured cells, the presence of pgp increased the apparent Km for the 6ß-hydroxylase activity of CYP3A4 toward testosterone and cortisol by a factor of 1.7 and 4, respectively. These steroids are poor and good substrates of pgp, respectively, and cortisol 6ß-hydroxylase has been frequently used as an in vivo probe for CYP3A4. Interestingly, we also found that pgp modulated the inhibition of CYP3A4-mediated metabolism by several compounds in intact cells. Although quinidine inhibited testosterone 6ß-hydroxylase activity in membranes or in intact cells that expressed recombinant CYP3A4 in the absence of pgp, low concentrations of this compound increased CYP3A4 activity in intact cells that expressed pgp. These results imply that pharmacokinetic drug-drug interactions involving CYP3A4 can be influenced by pgp.
AB - Some compounds used for phenotyping of cytochrome P450s are substrates of P-glycoprotein (pgp). It is likely that in these cases, the level of modulates the metabolism of in vivo probes. To address this important issue, we have analyzed the effects of pgp on CYP3A4-mediated reactions in two established cell lines (3A4/HR/MDR-and 3A4/HR/MDR+), which express CYP3A4 in the absence and presence of pgp respectively. In cultured cells, the presence of pgp increased the apparent Km for the 6ß-hydroxylase activity of CYP3A4 toward testosterone and cortisol by a factor of 1.7 and 4, respectively. These steroids are poor and good substrates of pgp, respectively, and cortisol 6ß-hydroxylase has been frequently used as an in vivo probe for CYP3A4. Interestingly, we also found that pgp modulated the inhibition of CYP3A4-mediated metabolism by several compounds in intact cells. Although quinidine inhibited testosterone 6ß-hydroxylase activity in membranes or in intact cells that expressed recombinant CYP3A4 in the absence of pgp, low concentrations of this compound increased CYP3A4 activity in intact cells that expressed pgp. These results imply that pharmacokinetic drug-drug interactions involving CYP3A4 can be influenced by pgp.
M3 - Article
SN - 1521-0103
VL - 296
SP - 351
EP - 358
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 2
ER -